(Q38324355)

2 September 2017

title

Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model (English)

1 reference

2 September 2017

0 references

Kawamura I

1

1 reference

2 September 2017

Morishita R

2

1 reference

2 September 2017

Tomita N

3

1 reference

2 September 2017

Lacey E

4

1 reference

2 September 2017

Aketa M

5

1 reference

2 September 2017

Tsujimoto S

6

1 reference

2 September 2017

Manda T

7

1 reference

2 September 2017

Tomoi M

8

1 reference

2 September 2017

Kida I

9

1 reference

2 September 2017

Higaki J

10

1 reference

2 September 2017

Kaneda Y

11

1 reference

2 September 2017

Shimomura K

12

1 reference

2 September 2017

Ogihara T

13

1 reference

2 September 2017

publication date

1 January 1999

1 reference

2 September 2017

1 reference

2 September 2017

volume

6

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

91-97

1 reference

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

1 reference

7 January 2021

Tumor necrosis factor and cachexia: a current perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Structure, regulation and function of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Function and activation of NF-kappa B in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Functional analysis of the human vascular cell adhesion molecule 1 promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

E2F and cell proliferation: a world turned upside down

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

A Restriction Point for Control of Normal Animal Cell Proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Cell-cycle control and its watchman.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Identification of a 70-base-pair cell cycle regulatory unit within the promoter of the human thymidine kinase gene and its interaction with cellular factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin‐6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300819

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3300819

1 reference

Dimensions Publication ID

2 September 2017

1044313971

0 references

1 reference